Methotrexate-associated osteonecrosis of the jaw: A report of two cases

Marianne Henien, Barbara Carey, Esther Hullah, Chris Sproat, Vinod Patel*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)


There has been a rise in medication-related osteonecrosis of the jaw (MRONJ) predominantly related to antiresorptive and antiangiogenic medications. More evidence is revealing that MRONJ is not limited to these drug groups. With the introduction of newer and varied medications used in the treatment of cancer and autoimmune diseases, reports of possible related osteonecrosis of the jaw (ONJ) are also on the rise. We present 2 cases of ONJ in patients with long-standing arthritis treated with methotrexate in the absence of a lymphoproliferative disorder and antiresorptive or antiangiogenic medications.

Original languageEnglish
JournalOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics
Early online date21 Sept 2017
Publication statusE-pub ahead of print - 21 Sept 2017


Dive into the research topics of 'Methotrexate-associated osteonecrosis of the jaw: A report of two cases'. Together they form a unique fingerprint.

Cite this